
Ceftina-XP 1000mg/125mg Injection
Marketer
Anikem Laboratories
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ceftina-XP 1000mg/125mg Injection
Combiflox, a 1000mg/125mg injectable formulation, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be strictly under medical guidance; consistent adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Seek immediate medical assistance for any allergic reaction (e.g., rash, pruritus, edema, dyspnea). Prior to initiation, disclose all current medications and pre-existing conditions to your physician. This includes informing your doctor if you are pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are vital for optimal recovery. Follow-up laboratory tests may be conducted to monitor treatment response.
Primary Ingredients of Ceftina-XP 1000mg/125mg Injection
There is no text provided to rephrase.
Uses of Ceftina-XP 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ceftina-XP 1000mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
Common Side effects of Ceftina-XP 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftina-XP 1000mg/125mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Ceftina-XP 1000mg/125mg Injection works:
Ceftriaxone and Tazobactum, combined as Ceftina-XP 1000mg/125mg Injection, offer targeted antibacterial action. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Ceftina-XP 1000mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ceftina-XP 1000mg/125mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; clinical data in humans, however, remain scarce.
Breast feedingCAUTION
The administration of Ceftina-XP 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Ceftina-XP 1000mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftina-XP 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The 1000mg/125mg Ceftina-XP injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for this injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceftina-XP 1000mg/125mg Injection :
Should you forget a scheduled Ceftina-XP 1000mg/125mg Injection, seek your physician's advice.
Facts to Know About Ceftina-XP 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
